Impact of Regorafenib and Sorafenib in the Treatment of Liver Cancer

Dr. Jordi Bruix, MD, head of the Barcelona Clinic Liver Cancer at University of Barcelona, discusses the major impact that regorafenib and sorafenib will have for the treatment of liver cancer.